RTC
BMY icon

Riverview Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Riverview Trust Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.1K Sell
1,254
-217
-15% -$12.7K 0.09% 97
2025
Q4 		$79.3K Hold
1,471
– – 0.1% 98
2025
Q3 		$66.3K Sell
1,471
-1,867
-56% -$87.2K 0.08% 115
2025
Q2 		$155K Sell
3,338
-497
-13% -$24.4K 0.19% 71
2025
Q1 		$234K Sell
3,835
-48
-1% -$2.8K 0.23% 76
2024
Q4 		$220K Buy
3,883
+511
+15% +$28.6K 0.2% 83
2024
Q3 		$174K Sell
3,372
-1,264
-27% -$59.3K 0.15% 107
2024
Q2 		$193K Buy
4,636
+1,388
+43% +$62.1K 0.18% 87
2024
Q1 		$176K Sell
3,248
-1,081
-25% -$55.1K 0.14% 109
2023
Q4 		$222K Hold
4,329
– – 0.23% 91
2023
Q3 		$251K Sell
4,329
-244
-5% -$15K 0.22% 76
2023
Q2 		$292K Sell
4,573
-794
-15% -$53.2K 0.27% 62
2023
Q1 		$372K Hold
5,367
– – 0.34% 51
2022
Q4 		$386K Sell
5,367
-657
-11% -$49.5K 0.37% 51
2022
Q3 		$428K Buy
6,024
+887
+17% +$64.3K 0.41% 49
2022
Q2 		$396K Hold
5,137
– – 0.35% 55
2022
Q1 		$375K Buy
5,137
+1,525
+42% +$102K 0.28% 62
2021
Q4 		$225 Buy
3,612
+1,577
+77% +$92.5K 0.13% 79
2021
Q3 		$120K Buy
2,035
+1,471
+261% +$96.9K 0.13% 109
2021
Q2 		$38K Hold
564
– – 0.04% 167
2021
Q1 		$36K Hold
564
– – 0.04% 163
2020
Q4 		$35K Hold
564
– – 0.04% 165
2020
Q3 		$34K Hold
564
– – 0.04% 164
2020
Q2 		$33K Sell
564
-63
-10% -$3.77K 0.03% 172
2020
Q1 		$35K Hold
627
– – 0.03% 162
2019
Q4 		$40K Hold
627
– – 0.03% 180
2019
Q3 		$32K Hold
627
– – 0.02% 193
2019
Q2 		$28K Hold
627
– – 0.02% 200
2019
Q1 		$30K Hold
627
– – 0.02% 197
2018
Q4 		$33K Buy
+627
New +$33.7K 0.03% 173

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Riverview Trust Company's BMY Position: Q1 2026 in Review

Riverview Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q1 2026, selling an estimated $12.7K and leaving 1,254 shares worth $76.1K. The position accounts for 0.09% of the portfolio, ranked #97.

Riverview Trust Company first reported a position in BMY in Q4 2018 and has held it in 30 quarters since. The position peaked at $428K in Q3 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Riverview Trust Company held 1,254 shares of Bristol-Myers Squibb worth $76.1K as of Q1 2026.
  • Riverview Trust Company sold 217 Bristol-Myers Squibb shares in Q1 2026, an estimated $12.7K.
  • Bristol-Myers Squibb made up 0.09% of Riverview Trust Company's portfolio in Q1 2026, its #97 holding.
  • Riverview Trust Company first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 30 quarters since.
  • Riverview Trust Company's Bristol-Myers Squibb position peaked at $428K in Q3 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Riverview Trust Company's 13F filing for Q1 2026, filed 1 May 2026.